Pfizer recently announced that several studies and analyses for its tofacitinib citrate (XELJANZ) treatment for rheumatoid arthritis (RA) will be featured at the European League Against Rheumatism Annual Congress (EULAR 2016). Read More »

The U.S. Food and Drug Administration’s (FDA) Advisory Committees has recommended extended-release capsules for ALO-02 from Pfizer. Read More »

McKesson detailed the occurrences of prescription abandonment tied to financial motivations in a recent article. Read More »

Pfizer announced last week that Jim Furyk has joined the company in advocating awareness for older individuals at risk for infectious diseases, including pneumococcal pneumonia. Read More »

CVS Pharmacies now open in Target store-in-store format; first CVS presence in Oregon. Read More »

ViiV Healthcare announced this week that it has reached a public tender agreement with the Botswana Ministry of Health to implement a "Treat All" program for HIV patients. Read More »

Rite Aid celebrated the opening of a new distribution center located in Spartanburg, S.C. this past week. Read More »

The U.S. Food and Drug Administration (FDA) announced this week that it has taken legal action against 4,402 websites that had been selling illicit prescription drugs and unapproved prescription drugs. Read More »

Store-in-store CVS Pharmacies open in Olympia, Seattle, Spokane and Tacoma. Read More »

New York State Senate is considering two bills that will exempt drugstores from safety and performance standards. Read More »

CVS Health's MinuteClinics now open in eight Maryland Target stores. Read More »

The American Pharmacists Association (APhA) announced the election results for the organization’s board of trustees. Read More »

The Business Council of New York State is not supporting legislation that seeks to amend the pharmaceutical law governing the purchase of prescription drugs. Read More »

(HS) education campaign designed to support those suffering from the skin disease. Read More »

The antiplatelet agent, Efient, is now available in 20 milligram form, Daiichi Sankyo recently announced. Read More »

Analysis of the Phase III ANCHOR trial to be displayed in a poster presentation. Read More »

The U.S. Food and Drug Administration (FDA) added information on using the St. George’s Respiratory Questionnaire (SGRQ) in its newest version of draft guidance in drug development for Chronic Obstructive Pulmonary Disease (COPD). Read More »

Early relapsing patients treated with Kyprolis (carfilzomib) in combination with lenalidomide and dexamethasone (KRd) showed median PFS of 24.1 months. Read More »

Survey reveals that students learn best with hands-on experiments and field trips. Read More »

Positive trial results in treating CLL/SLL; favorable PFS and OS shown in longer-term follow up data. Read More »